For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Compensation | 3,635,756 | 2,527,772 | ||
| Professional fees | 1,441,659 | 1,167,249 | ||
| Information technology | 95,989 | 38,658 | ||
| General and administrative-other | 836,076 | 329,660 | ||
| Total general and administrative costs | 6,009,480 | 4,063,339 | ||
| Research and development costs | 3,706,991 | 1,868,766 | ||
| Total operating costs | 9,716,471 | 5,932,105 | ||
| Net operating loss | -9,716,471 | -5,932,105 | ||
| Interest income, net | 363,786 | 77,612 | ||
| Change in fair value of safe | - | -8 | ||
| Other income/(expense) | 88,746 | -6,834 | ||
| Loss before income taxes | -9,263,939 | -5,861,335 | ||
| Income tax benefit | -105,205 | - | ||
| Net loss | -9,158,734 | -5,861,335 | ||
| Basic EPS | -1.09 | -0.89 | ||
| Diluted EPS | -1.09 | -0.89 | ||
| Basic Average Shares | 8,381,444 | 6,563,255 | ||
| Diluted Average Shares | 8,381,444 | 6,563,255 | ||
EXOZYMES INC. (EXOZ)
EXOZYMES INC. (EXOZ)